ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1006

Dynamic Gene Expression of Wnt Signaling Pathway During Osteogenic Stimulation in Vitro of Osteoarthritis Mesenchymal Stem Cells

A. Peralta-Sastre1, M. Hernandez-Molinero2, P. Tornero-Esteban2, E. Villafuertes2, B. Fernandez-Gutierrez3 and Jose Ramon Lamas2, 1UGC de Reumatología, 1UGC de Reumatología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., 2Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 3Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Mesenchymal stem cells and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The role of Wnt signalling in Mesenchymal Stem Cell (MSC) fate is still unclarified. Both, canonical and non-canonical pathways have been implicated in differentiation and proliferation resulting from specific Wnt ligands, receptors, inhibitors and downstream molecules responsible for the signalling and/or the developmental commitment. Although osteogenesis is a well-studied process, molecular details remain unknown. Te aim of the study was to delineate the changes in gene expression of Wnt related occurring during osteogenesis in OA and control patients.

 

Methods:

MSCs were obtained from bone marrow aspirates at the time of joint replacement surgery of five OA patients (mean 76 years) and three control subjects without OA signs (mean 80 years). Cells were cultured and expanded under osteogenic stimuli. Confluent cells in passage 6 were collected at days 1, 10 and 21. RNA was purified and retrotranscribed prior quantitative PCR analysis. Simultaneous gene expression of 84 Wnt related genes was analysed using the Human Wnt  PCR Array PAHS-043A, from SABiosciences according. The resulting expression raw data was analyzed using the SABiosciences web-based PCR Array Data Analysis tool. ΔΔCt values relative to the RPL13A housekeeping gene were used to calculate the expression changes. Two-fold changes with p<0.05 were considered significative.

 

Results:

MSCs from OA patients undergoing osteogenesis progressively increases the number of downregulated genes related to the Wnt signaling. While at basal conditions only two genes were downregulated, at days 10 and 21, twelve and sixteen genes were downregulated respectively. Among downregulated genes, some encode for essential proteins participating both in canonical and non-canonical Wnt pathway and including several ligands, co-rreceptors, inhibitors, kinases and transcription factors.

 

Conclusion:

Our data demosnstrate a clear alteration during osteogenesis of MSCs biology from OA patients. We hypothesized that a possible cause of OA may lie in these intrinsic alterations of MSCs preventing proper differentiation into fully functional adult tissues.



Disclosure:

A. Peralta-Sastre,
None;

M. Hernandez-Molinero,
None;

P. Tornero-Esteban,
None;

E. Villafuertes,
None;

B. Fernandez-Gutierrez,
None;

J. R. Lamas,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dynamic-gene-expression-of-wnt-signaling-pathway-during-osteogenic-stimulation-in-vitro-of-osteoarthritis-mesenchymal-stem-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology